An insight into Science Creates
Founded by exited entrepreneurs, Science Creates is a Deep Tech ecosystem that enables scientists and engineers to turn their groundbreaking discoveries into disruptive businesses that can revolutionise the health of people and the planet.
We support our startup community with specialised lab space, expert training and mentoring, a network of partner organisations, and access to investment opportunities.
Through our independent charity and public events, we inspire the next generation of scientists and entrepreneurs.





Our ethos
We believe the next big breakthroughs will emerge at the intersection of fields like quantum, AI, and biotechnology — and that spinouts are the most powerful way to turn those innovations into global impact.
The first step is empowering those at the forefront of knowledge with the right infrastructure, training, resources and investment.
Science Creates is laying the foundations for bold ideas and innovation to thrive and scale, nationwide.
Designed for flexibility, OMX, our new 30,000 sq ft of lab, office, and meeting space for startups and scaleups is set to open in March 2026 in Bristol’s city centre.
We currently welcome applications from service providers working in legal, IT, grants, cloud, bespoke software and marketing.
We invest in Deep Tech at the pre-seed and seed stages — and our endgame is global impact.
.webp)


Our focus
Deep Tech refers to innovations based on major breakthroughs in science and engineering, often built on years of research and proprietary technology to solve global challenges. Unlike regular tech, it focuses on transformative, long-term solutions in fields like AI, quantum, synthetic biology and advanced materials.
Deep Tech has the power to revolutionise industries, create new markets, and improve lives. From AI-driven healthcare to sustainable energy and quantum technologies, it tackles critical global issues.
We specialise in Deep Tech for its potential to drive systemic change and create significant impact, providing patient capital and strategic support to turn groundbreaking ideas into scalable businesses.

Medusa Materials is transforming carbon dioxide into carbon-negative minerals to drive sustainability in the construction industry. Its MEDUSA system takes carbon captured from sources like cement kilns, coal power plants, beer fermenters and even the air, using biological agents and waste materials to convert it into limestone and carbonate crystals. These can be used in concrete as a cement supplement, reducing atmospheric carbon, cutting cement consumption for greener, more resilient building materials.

IsomAb is developing isoform specific antibodies to treat patients with diseases that currently have limited or no treatment options. Its bioinformatics and knowledge-based platform approach has identified the therapeutic antibody ISM-001 as a development candidate for peripheral arterial disease (PAD). By progressing this through clinical trials, it has the potential to significantly improve the wellbeing of those affected by PAD which causes risk factors such as type 2 diabetes, obesity and high blood pressure.

ProPrep is developing novel protein production technologies to reduce costs and increase productivity for scientists who produce proteins to detect, treat and prevent disease.



Available for hire for those working in the innovation sector, our versatile spaces can welcome a variety of events.
